Tarsus Pharmaceuticals (TARS) Debt to Equity (2022 - 2026)
Tarsus Pharmaceuticals (TARS) recorded quarterly Debt to Equity of $0.21 in Q1 2026, down 1.37% quarter-over-quarter from $0.21 in Q4 2025, and down 1.02% on a YoY basis from $0.21 in Q1 2025.
Tarsus Pharmaceuticals (TARS) Debt to Equity (2022 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Debt to Equity history runs 5 years deep, the most recent figure standing at $0.21 for Q1 2026.
- In Q1 2026, Debt to Equity fell 1.02% year-over-year to $0.21; the TTM figure through Mar 2026 stood at $0.21 (down 1.02% YoY), while the FY2025 annual figure was $0.21, down 34.08% from the prior year.
- Debt to Equity was $0.21 for Q1 2026 at Tarsus Pharmaceuticals, down from $0.21 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.32 in Q4 2024 to a low of $0.09 in Q2 2022.
- Historically, Debt to Equity has averaged $0.18 across 5 years, with a median of $0.17 in 2023.
- The sharpest annual moves came in 2024 and 2025: Debt to Equity surged 117.17% in 2024, then slumped 34.08% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.1 in 2022, then surged by 50.25% to $0.15 in 2023, then surged by 111.38% to $0.32 in 2024, then plunged by 34.08% to $0.21 in 2025, then retreated by 1.37% to $0.21 in 2026.
- The last three Debt to Equity figures came in at $0.21 (Q1 2026), $0.21 (Q4 2025), and $0.22 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.71 Bn | 2.61 Bn | 152.66 Mn | 0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.21 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.28 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.14 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.13 |